Ubikare
PrivateLast Round
Grant
Jan 28, 2022
Total Funding Raised
$1.63M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ubikare is a health-tech company that develops modular software solutions and the NAIHA (Natural & Artificial Intelligence Health Assistant) platform to optimize management and care in the healthcare and socio-health sectors.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Quantum Computing, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ubikare Comparables
Compare Ubikare with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dassault Systèmes | 68% | |
| Veeva Systems | 65% | |
| Castor | 64% | |
Ubikare Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 28, 2022 | ||||
| Corporate Funding | Sep 21, 2021 | ||||
| Seed | Jul 14, 2020 | ||||
| Seed | Jan 8, 2020 |
Ubikare Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Seed Capital Bizkaia | Seed |
| Mutua Ventures | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 14, 2026
Partnered with Vicomtech and Multiverse Computing on Q-CLINIC initiative.
- Apr 14, 2026
Launched Q-CLINIC, applying quantum algorithms to clinical data management.
Ubikare Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ubikare's valuation, stock price, and market status.